PNEUMONIA IN PATIENTS WITH BRONCHO-OBSTRUCTIVE DISEASES TREATED WITH INHALED GLUCOCORTICOSTEROIDS
Relevance. The use of inhaled glucocorticosteroids (IHCs) is one of the main basic treatment options forbroncho-obstructive diseases.IHCs suppress chronic inflammation in the bronchial tree, but can be associated with the risk of pneumonia due to impairment of bronchus mucosal immunity and increased...
Saved in:
| Main Authors: | E. A. Kulagin, V. I. Trofimov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Academician I.P. Pavlov First St. Petersburg State Medical University
2017-06-01
|
| Series: | Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова |
| Subjects: | |
| Online Access: | https://www.sci-notes.ru/jour/article/view/383 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of systemic glucocorticosteroids in the management of asthma and chronic obstructive pulmonary disease exacerbation on respiratory microbiota composition in the period of stability
by: S. V. Fedosenko, et al.
Published: (2017-01-01) -
Bronchodilator reversibility test for broncho-obstructive syndrome detection and differential diagnosis of bronchial asthma and chronic obstructive pulmonary disease
by: V. P. Melnyk, et al.
Published: (2019-04-01) -
PEDIATRIC BRONCHIAL ASTHMA: MODERN TREATMENT ASPECTS
by: O.V. Zaitseva, et al.
Published: (2011-11-01) -
The Use of Inhaled Glucocorticosteroids (ICS) during the COVID-19 Pandemic
by: A. A. Vizel, et al.
Published: (2022-02-01) -
Treatment with oral or inhaled bronchodilator without inhaled corticosteroids in bronchial asthma: A dangerous weapon!
by: Shital Patil, et al.
Published: (2023-05-01)